A retrospective study on socio-demographic, clinicopathological, molecular subtypes and comorbidities of women with breast cancer
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261692Keywords:
Breast cancer, Tumor characteristics, Molecular subtypes, Comorbidities, Body mass index, Retrospective studyAbstract
Background: Breast cancer is a heterogeneous disease influenced by demographic factors, tumor biology, and comorbid conditions. Understanding these characteristics is essential for improving early detection and management strategies.
Methods: We conducted a cross-sectional retrospective study using data from 120 women diagnosed with breast cancer. Demographic data (age, BMI), socioeconomic status, education level, clinical symptoms, radiologic findings, pathology reports, tumor grade, Modified Bloom-Richardson Score, molecular subtypes, comorbidities and presence of metastasis were obtained from patient charts and analysed descriptively.
Results: The majority of breast cancer patients were middle-aged; with the range of 36-55 years old. Many patients had high BMIs. The most common presenting symptom of breast cancer was a palpable breast lump. Histologically, invasive ductal carcinoma was the most common type, and the majority of the tumors were classified as high-grade and had high modified bloom-Richardson scores. The most common molecular subtype of breast cancer in our population was luminal A, followed by triple negative. Hypertension and Type 2 diabetes mellitus were the most common comorbidities in this population.
Conclusions: Breast cancer patients appeared to be diagnosed at a later stage than previously reported and the tumors were highly aggressive. The implications of our findings support increased public awareness, earlier detection, and targeted screening programs, particularly in rural and underserved populations.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49.
WHO. Breast cancer: fact sheet. Geneva (CH): World Health Organization. 2025. Available at: https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Accessed on 28 February 2026.
Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol. 2017;13(4):289-95.
Gupta A, Shridhar K, Dhillon PK. A review of breast cancer awareness among women in India: Cancer literate or awareness deficit?. Eur J Cancer. 2015;51(14):2058-66.
Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst. 2011;103(19):1476-80.
Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93(9):1046-52.
Perou CM, Sørlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-52.
Maurya AP, Brahmachari S. Current status of breast cancer management in India. Indian J Surg. 2021;83(2):316-21.
Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568-74.
Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337-50.
Jonnada PK, Sushma C, Karyampudi M, Dharanikota A. Prevalence of Molecular Subtypes of Breast Cancer in India: a Systematic Review and Meta-analysis. Indian J Surg Oncol. 2021;12(1):152-63.
Ebrahimoghli R, Aghaei MH, Azami-Aghdash S, Houssami N. Uptake of breast cancer screening practices in low- and middle-income countries: a systematic review and meta-analysis. J Natl Cancer Inst. 2025;117(1):29-39.
Pandey A, Raj S, Madhawi R, Devi S, Singh RK. Cancer trends in Eastern India: Retrospective hospital-based cancer registry data analysis. South Asian J Cancer. 2019;8(4):215-7.
Luís C, Dias J, Firmino-Machado J, Fernandes R, Pereira D, Baylina P, et al. A retrospective study in tumour characteristics and clinical outcomes of overweight and obese women with breast cancer. Breast Cancer Res Treat. 2023;198(1):89-101.
Hewage SA, Samaraweera S, Joseph N, Kularatna S, Gunawardena N. Presentation, Diagnosis and Treatment Delays in Breast Cancer Care and Their Associations in Sri Lanka, a Low-resourced Country. Clin Oncol (R Coll Radiol). 2022;34(9):598-607.
Nene BM, Selmouni F, Lokhande M, Hingmire SJ, Muwonge R, Jayant K, et al. Patterns of Care of Breast Cancer Patients in a Rural Cancer Center in Western India. Indian J Surg Oncol. 2018;9(3):374-80.
Shrivastava N. A Retrospective Analysis of Breast Cancer Presentation Among Young and Older Women in an Indian Cohort of 70 Patients. Cureus. 2024;16(5):e61239.
Sandhu GS, Erqou S, Patterson H, Mathew A. Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis. J Glob Oncol. 2016;2(6):412-21.
Kulkarni A, Kelkar DA, Parikh N, Shashidhara LS, Koppiker CB, Kulkarni M. Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer. JCO Glob Oncol. 2020;6:1052-62.
Kumar N, Patni P, Agarwal A, Khan MA, Parashar N. Prevalence of molecular subtypes of invasive breast cancer: A retrospective study. Med J Armed Forces India. 2015;71(3):254-8.
Rathod V, Jha CK, Sinha U, Singh PK, Kumar A, Bhadani PP, et al. First Comprehensive Report of Clinicopathological Profile of Breast Cancer from Bihar, India. Indian J Surg Oncol. 2021;12(3):598-602.
Suhani S, Kazi M, Parshad R, Seenu V, Verma E, Mathur S, et al. An audit of over 1000 breast cancer patients from a tertiary care center of Northern India. Breast Dis. 2020;39(2):91-9.
Downloads
Published
How to Cite
Issue
Section
